Literature DB >> 11004111

Appraising evaluations of screening/diagnostic tests: the importance of the study populations.

R Harper1, D Henson, B C Reeves.   

Abstract

Mesh:

Year:  2000        PMID: 11004111      PMCID: PMC1723243          DOI: 10.1136/bjo.84.10.1198

Source DB:  PubMed          Journal:  Br J Ophthalmol        ISSN: 0007-1161            Impact factor:   4.638


× No keyword cloud information.
  17 in total

1.  A population-based evaluation of glaucoma screening: the Baltimore Eye Survey.

Authors:  J M Tielsch; J Katz; K Singh; H A Quigley; J D Gottsch; J Javitt; A Sommer
Journal:  Am J Epidemiol       Date:  1991-11-15       Impact factor: 4.897

2.  Prevention of blindness from glaucoma using the King's College Hospital computerized problem orientated medical record.

Authors:  R P Crick
Journal:  Br J Ophthalmol       Date:  1975-04       Impact factor: 4.638

3.  Users' guides to the medical literature. III. How to use an article about a diagnostic test. B. What are the results and will they help me in caring for my patients? The Evidence-Based Medicine Working Group.

Authors:  R Jaeschke; G H Guyatt; D L Sackett
Journal:  JAMA       Date:  1994-03-02       Impact factor: 56.272

4.  Racial variations in the prevalence of primary open-angle glaucoma. The Baltimore Eye Survey.

Authors:  J M Tielsch; A Sommer; J Katz; R M Royall; H A Quigley; J Javitt
Journal:  JAMA       Date:  1991-07-17       Impact factor: 56.272

5.  Comparing the areas under two or more correlated receiver operating characteristic curves: a nonparametric approach.

Authors:  E R DeLong; D M DeLong; D L Clarke-Pearson
Journal:  Biometrics       Date:  1988-09       Impact factor: 2.571

6.  Users' guides to the medical literature. III. How to use an article about a diagnostic test. A. Are the results of the study valid? Evidence-Based Medicine Working Group.

Authors:  R Jaeschke; G Guyatt; D L Sackett
Journal:  JAMA       Date:  1994-02-02       Impact factor: 56.272

7.  Efficient study designs to assess the accuracy of screening tests.

Authors:  L Irwig; P P Glasziou; G Berry; C Chock; P Mock; J M Simpson
Journal:  Am J Epidemiol       Date:  1994-10-15       Impact factor: 4.897

8.  Glaucoma screening: the importance of combining test data.

Authors:  R A Harper; B C Reeves
Journal:  Optom Vis Sci       Date:  1999-08       Impact factor: 1.973

9.  Relationship between intraocular pressure and primary open angle glaucoma among white and black Americans. The Baltimore Eye Survey.

Authors:  A Sommer; J M Tielsch; J Katz; H A Quigley; J D Gottsch; J Javitt; K Singh
Journal:  Arch Ophthalmol       Date:  1991-08

10.  Maximising the sensitivity and specificity of non-contact tonometry in glaucoma screening.

Authors:  S A Vernon; S J Jones; D J Henry
Journal:  Eye (Lond)       Date:  1991       Impact factor: 3.775

View more
  6 in total

1.  Evidence about evidence.

Authors:  B C Reeves
Journal:  Br J Ophthalmol       Date:  2005-03       Impact factor: 4.638

2.  The quality of reporting of diagnostic accuracy studies published in ophthalmic journals.

Authors:  M A R Siddiqui; A Azuara-Blanco; J Burr
Journal:  Br J Ophthalmol       Date:  2005-03       Impact factor: 4.638

3.  Assessing sensitivity and specificity in new diagnostic tests: the importance and challenges of study populations.

Authors:  Paula Strassle; Aaron S Hess; Kerri A Thom; Anthony D Harris
Journal:  Infect Control Hosp Epidemiol       Date:  2012-11       Impact factor: 3.254

Review 4.  Screening tests: a review with examples.

Authors:  L Daniel Maxim; Ron Niebo; Mark J Utell
Journal:  Inhal Toxicol       Date:  2014-09-29       Impact factor: 2.724

5.  Expanding the traditional role of optometry: Current practice patterns and attitudes to enhanced glaucoma services in Ireland.

Authors:  Catriona Barrett; James Loughman
Journal:  J Optom       Date:  2018-04-09

6.  The language of evidence based medicine: answers to common questions?

Authors:  Ryan M Degen; Justin L Hodgins; Mohit Bhandari
Journal:  Indian J Orthop       Date:  2008-04       Impact factor: 1.251

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.